Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 10,964 shares at $50.42 ($553K) on 2024-01-17, disclosed to the SEC on 2024-01-18.
Seasonal sale ($553k) by EVP, Chf Clinical Develop Ofcr — this insider has traded IONS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.42 | 5,482 | $276K | 50.0% |
| 2 | $50.42 | 5,482 | $276K | 50.0% |
| Total | $50.42 avg | 10,964 | $553K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |